| abstract |
The present invention relates to the use of a compound of formula I n n n wherein n R 2 is R—NH wherein R is a branched or unbranched alkyl radical, a piperidinyl group or pyrrolidinyl group, each of which may be optionally substituted by one or more —OH, halogen, amino or hydroxyalkyl groups; n R 6 is phenylamino, benzylamino or pyridyl-methylamino, indan-5-amino, where in each case the aryl group may be unsubstituted or substituted by one or more —OR″, halogen, NO 2 , amino or COOR′ groups, wherein R′ and R″ are each independently H or a branched or unbranched alkyl group; and n R 9 is a branched or unbranched alkyl group or a cycloalkyl group; n in the treatment of an autoimmune disorder. n The invention further relates to a method of treating an autoimmune disorder comprising administering to a subject in need thereof a therapeutically effective amount of a compound of formula I. |